Skip to main content
Lippincott Open Access logoLink to Lippincott Open Access
. 2022 Oct 7;40(11):2322. doi: 10.1097/HJH.0000000000003309

Renal denervation in the antihypertensive arsenal – knowns and known unknowns: Erratum

PMCID: PMC10470425  PMID: 36205018

In this article by Messerli et al.[1], table 2 was incorrectly published. The correct table 2 is shown below:

TABLE 2.

Antihypertensive effects of beta-blockers, RAS blockers, calcium-channel blockers, thiazides and renal denervation.

Beta-blockers RAS blockers Calcium-channel blockers Thiazides Renal denervation
BP decrease, sustainability years, decades years, decades years, decades years, decades months
BP paradox responders yes ? no no yes
BP variability ? ? ↓↓↓ ↓↓
BP decrease age dependent yes yes no no yes
Heart rate ↓↓ no no no
Plasma renin activity ↓↓ ↑↑↑ ?↑ ↑↑ ↓↓
Sympathetic activity ↓↓ no ↓↓
Morbidity and mortality inconsistent evidence ↓↓ ↓↓ ↓↓↓ no evidence

REFERENCE

  • 1.Messerli FH, Bavishi C, Brguljan J, Burnier M, Dobner S, et al. Renal denervation in the antihypertensive arsenal - knowns and known unknowns. J Hypertens 2022; 40:1859–1875. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Hypertension are provided here courtesy of Wolters Kluwer Health

RESOURCES